Ovarian cyst removal can improve health and may lead to weight loss by decreasing inflammation and fluid retention. Learn ...

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is one of Goldman Sachs’ top healthcare stock picks. On July 1, the European Commission approved the company’s new cystic fibrosis treatment ...

All eligible people with CF in England can now benefit from this medicine - LONDON - July 15, 2025 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that it has reached a broad ...

BiomX has dosed the first subject in the randomised Phase IIb trial of the multi-phage therapy, BX004, to treat cystic fibrosis (CF).

Super-resolution ultrasound (SRUS) has evolved significantly with the advent of ultrasound localization microscopy (ULM). This technique enables subwavelength resolution imaging using microbubble ...

Ultrasound (US) is generally preferred because it is of low-cost, safe, and non-invasive. US image segmentation is crucial in image analysis. Recently, deep learning-based methods are increasingly ...

Keywords: modified thoracoabdominal nerve block, laparoscopic renal cyst decompression, postoperative analgesia, ultrasound, randomized controlled trial Citation: Wan M, Dong J, Wei K, Jin J, Cao J ...

VRTX secures EU approval for Alyftrek, a next-in-class triple combination regimen for treating people with CF aged six years and older.

As a result of reimbursement agreements in Ireland and Denmark and provisions for access in health care systems such as Germany, eligible patients in these countries will have access to ...